The microRNA network is altered in anterior cingulate cortex of patients with unipolar and bipolar depression

Journal of Psychiatric Research

Volumn 82, Issue , 2016, Pages 58-67

  Azevedo, Joshua A ^a,b   Carter, Bradley S ^a,b,c   Meng, Fan ^a,d,j   Turner, David L ^a,b,k   Dai, Manhong ^a   Schatzberg, Alan F ^d,e   Barchas, Jack D ^d,f   Jones, Edward G ^d,g   Bunney, William E ^d,h   Myers, Richard M ^d,i   Akil, Huda ^a,b,d,j   Watson, Stanley J ^a,b,d,j   Thompson, Robert C ^a,b,d,j  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c OBERLIN COLLEGE   (United States)

^d Pritzker Neuropsychiatric Disorders Research Consortium   (United States)

^e STANFORD UNIVERSITY   (United States)

^f WEILL CORNELL MEDICAL COLLEGE   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ HUDSONALPHA INSTITUTE FOR BIOTECHNOLOGY   (United States)

^j UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^k UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

more..

Author keywords

Anterior cingulate cortex; microRNA; Mood disorders

Indexed keywords

LUCIFERASE; MESSENGER RNA; MICRORNA; MICRORNA 132; MICRORNA 133A; MICRORNA 184; MICRORNA 212; MICRORNA 34A; NUCLEAR COACTIVATOR 1; NUCLEAR PROTEIN; PHOSPHODIESTERASE; PHOSPHODIESTERASE 4B; SILENCING MEDIATOR OF RETINOID AND THYROID HORMONE RECEPTOR; SMALL UNTRANSLATED RNA; UNCLASSIFIED DRUG; NCOA1 PROTEIN, HUMAN; NCOA2 PROTEIN, HUMAN; NUCLEAR RECEPTOR COACTIVATOR 2; PHOSPHODIESTERASE IV; SIRT1 PROTEIN, HUMAN; SIRTUIN 1; STEROID RECEPTOR COACTIVATOR 1;

ANTERIOR CINGULATE; ARTICLE; BIPOLAR DEPRESSION; BIPOLAR DISORDER; BRAIN TISSUE; CENTRAL NERVOUS SYSTEM; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATIONAL STUDY; GENE EXPRESSION; GENE TARGETING; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LUCIFERASE ASSAY; MAJOR DEPRESSION; MENTAL DISEASE; MENTAL PATIENT; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHIZOPHRENIA; STEADY STATE; STRESS; TISSUE SECTION; ADULT; AGED; ALGORITHM; CINGULATE GYRUS; FEMALE; GENETIC TRANSFECTION; GENETICS; HEK293 CELL LINE; MALE; METABOLISM; MIDDLE AGED; MUTAGENESIS; PATHOLOGY; POSTMORTEM CHANGE; YOUNG ADULT;

ADULT; AGED; ALGORITHMS; BIPOLAR DISORDER; CYCLIC NUCLEOTIDE PHOSPHODIESTERASES, TYPE 4; DEPRESSIVE DISORDER, MAJOR; FEMALE; GYRUS CINGULI; HEK293 CELLS; HUMANS; MALE; MICRORNAS; MIDDLE AGED; MUTAGENESIS; NUCLEAR RECEPTOR COACTIVATOR 1; NUCLEAR RECEPTOR COACTIVATOR 2; POSTMORTEM CHANGES; RNA, MESSENGER; SIRTUIN 1; TRANSFECTION; YOUNG ADULT;

EID: 84979207888     PISSN: 00223956     EISSN: 18791379     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2016.07.012     Document Type: Article

References (95)

1. Abe, N., Uchida, S., Otsuki, K., Hobara, T., Yamagata, H., Higuchi, F., Shibata, T., Watanabe, Y., Altered sirtuin deacetylase gene expression in patients with a mood disorder. J. Psychiatr. Res. 45:8 (2011), 1106–1112.
2. Altamura, A.C., Boin, F., Maes, M., HPA axis and cytokines dysregulation in schizophrenia: potential implications for the antipsychotic treatment. Eur. Neuropsychopharmacol. 10 (1999), 1–4.
3. Bahi, A., Chandrasekar, V., Dreyer, J.L., Selective lentiviral-mediated suppression of microRNA124a in the hippocampus evokes antidepressants-like effects in rats. Psychoneuroendocrinology 46 (2014), 78–87.
4. Bak, M., Silahtaroglu, A., Moller, M., Christensen, M., Rath, M.F., Skryabin, B., et al. MicroRNA expression in the adult mouse central nervous system. RNA 14 (2008), 432–444.
5. Bavamian, S., Mellios, N., Lalonde, J., Fass, D.M., Wang, J., Sheridan, S.D., et al. Dysregulation of miR-34a links neuronal development to genetic risk factors for bipolar disorder. Mol. Psychiatry 20:5 (2015), 573–584.
6. Benjamini, H., Hochberg, Y., Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing. J Royal Stat. Soc. Series B, 57, 1995.
7. Berent, D., Macander, M., Szemraj, J., Orzechowska, A., Galecki, P., Vascular endothelial growth factor A gene expression level is higher in patients with major depressive disorder and not affected by cigarette smoking, hyperlipidemia or treatment with statins. Acta Neurobiol. Exp. (Wars) 74:1 (2014), 82–90.
8. Berrettini, W., Evidence for shared susceptibility in bipolar disorder and schizophrenia. Am. J. Med. Genet. C Semin. Med. Genet. 123C (2003), 59–64.
9. Betel, D., Koppal, A., Agius, P., Sander, C., Leslie, C., Comprehensive modeling of microRNA targets predicts functional non-conserved and non-canonical sites. Genome Biol., 11, 2010, R90.
10. Beveridge, N.J., Gardiner, E., Carroll, A.P., Tooney, P.A., Cairns, M.J., Schizophrenia is associated with an increase in cortical microRNA biogenesis. Mol. Psychiatry 15 (2010), 1176–1189.
11. Beveridge, N.J., Tooney, P.A., Carroll, A.P., Gardiner, E., Bowden, N., Scott, R.J., et al. Dysregulation of miRNA 181b in the temporal cortex in schizophrenia. Hum. Mol. Genet. 17 (2008), 1156–1168.
12. Bierut, L.J., Heath, A.C., Bucholz, K.K., Dinwiddie, S.H., Madden, P.A., Statham, D.J., et al. Major depressive disorder in a community-based twin sample: are there different genetic and environmental contributions for men and women?. Arch. Gen. Psychiatry 56 (1999), 557–563.
13. Bradshaw, N.J., Ogawa, F., Antolin-Fontes, B., Chubb, J.E., Carlyle, B.C., Christie, S., et al. DISC1, PDE4B, and NDE1 at the centrosome and synapse. Biochem. Biophys. Res. Commun. 377 (2008), 1091–1096.
14. Breslau, N., Davis, G.C., Chronic stress and major depression. Arch. Gen. Psychiatry 43 (1986), 309–314.
15. Broderick, J.A., Salomon, W.E., Ryder, S.P., Aronin, N., Zamore, P.D., Argonaute protein identity and pairing geometry determine cooperativity in mammalian RNA silencing. RNA 17 (2011), 1858–1869.
16. Bunney, B.G., Li, J.Z., Walsh, D.M., Stein, R., Vawter, M.P., Cartagena, P., et al. Circadian dysregulation of clock genes: clues to rapid treatments in major depressive disorder. Mol. Psychiatry 20 (2015), 48–55.
17. Burton, P.R., Clayton, D.G., Cardon, L.R., Craddock, N., Deloukas, P., Duncanson, A., et al. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447:7145 (2007), 661–678.
18. Cao, X., Yeo, G., Muotri, A.R., Kuwabara, T., Gage, F.H., Noncoding RNAs in the mammalian central nervous system. Annu. Rev. Neurosci. 29 (2006), 77–103.
19. Cheng, H.Y., Papp, J.W., Varlamova, O., Dziema, H., Russell, B., Curfman, J.P., et al. microRNA modulation of circadian-clock period and entrainment. Neuron 54 (2007), 813–829.
20. Cui, Y., Xiao, Z., Han, J., Sun, J., Ding, W., Zhao, Y., et al. MiR-125b orchestrates cell proliferation, differentiation and migration in neural stem/progenitor cells by targeting nestin. BMC Neurosci., 13, 2012, 116.
21. Daban, C., Vieta, E., Mackin, P., Young, A.H., Hypothalamic-pituitary-adrenal axis and bipolar disorder. Psychiatr. Clin. North Am. 28 (2005), 469–480.
22. Diler, R.S., Pan, L.A., Segreti, A., Ladouceur, C.D., Forbes, E., Cela, S.R., et al. Differential anterior cingulate activity during response inhibition in depressed adolescents with bipolar and unipolar major depressive disorder. J. Can. Acad. Child. Adolesc. Psychiatry 23 (2014), 10–19.
23. Drevets, W.C., Savitz, J., Trimble, M., The subgenual anterior cingulate cortex in mood disorders. CNS Spectr. 13 (2008), 663–681.
24. Ebert, D., Ebmeier, K.P., The role of the cingulate gyrus in depression: from functional anatomy to neurochemistry. Biol. Psychiatry 39 (1996), 1044–1050.
25. Evans, S.J., Choudary, P.V., Neal, C.R., Li, J.Z., Vawter, M.P., Tomita, H., et al. Dysregulation of the fibroblast growth factor system in major depression. Proc. Natl. Acad. Sci. U. S. A. 101 (2004), 15506–15511.
26. Evans, S.J., Choudary, P.V., Vawter, M.P., Li, J., Meador-Woodruff, J.H., Lopez, J.F., et al. DNA microarray analysis of functionally discrete human brain regions reveals divergent transcriptional profiles. Neurobiol. Dis. 14 (2003), 240–250.
27. Fan, H.M., Sun, X.Y., Guo, W., Zhong, A.F., Niu, W., Zhao, L., et al. Differential expression of microRNA in peripheral blood mononuclear cells as specific biomarker for major depressive disorder patients. J. Psychiatr. Res. 59 (2014), 45–52.
28. Fatemi, S.H., King, D.P., Reutiman, T.J., Folsom, T.D., Laurence, J.A., Lee, S., et al. PDE4B polymorphisms and decreased PDE4B expression are associated with schizophrenia. Schizophr. Res. 101 (2008), 36–49.
29. Fleischhacker, W.W., Hinterhuber, H., Bauer, H., Pflug, B., Berner, P., Simhandl, C., et al. A multicenter double-blind study of three different doses of the new cAMP-phosphodiesterase inhibitor rolipram in patients with major depressive disorder. Neuropsychobiology 26 (1992), 59–64.
30. Fujino, J., Yamasaki, N., Miyata, J., Sasaki, H., Matsukawa, N., Takemura, A., et al. Anterior cingulate volume predicts response to cognitive behavioral therapy in major depressive disorder. J. Affect Disord. 174 (2015), 397–399.
31. Gibbons, J.L., Mc, H.P., Plasma cortisol in depressive illness. J. Psychiatr. Res. 1 (1962), 162–171.
32. Halsey, L.G., Curran-Everett, D., Vowler, S.L., Drummond, G.B., The fickle P value generates irreproducible results. Nat. Methods 12:3 (2015), 179–185.
33. Haramati, S., Navon, I., Issler, O., Ezra-Nevo, G., Gil, S., Zwang, R., et al. MicroRNA as repressors of stress-induced anxiety: the case of amygdalar miR-34. J. Neurosci. 31 (2011), 14191–14203.
34. Honda, M., Kuwano, Y., Katsuura-Kamano, S., Kamezaki, Y., Fujita, K., Akaike, Y., et al. Chronic academic stress increases a group of microRNAs in peripheral blood. PLoS One, 8, 2013, e75960.
35. Huang da, W., Sherman, B.T., Lempicki, R.A., Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 37 (2009), 1–13.
36. Huang da, W., Sherman, B.T., Lempicki, R.A., Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 4 (2009), 44–57.
37. Ilgen, M.A., Hutchison, K.E., A history of major depressive disorder and the response to stress. J. Affect Disord. 86 (2005), 143–150.
38. Jacobsen, A., Wen, J., Marks, D.S., Krogh, A., Signatures of RNA binding proteins globally coupled to effective microRNA target sites. Genome Res. 20 (2010), 1010–1019.
39. Jakovljevic, M., Muck-Seler, D., Pivac, N., Crncevic, Z., Platelet 5-HT and plasma cortisol concentrations after dexamethasone suppression test in patients with different time course of schizophrenia. Neuropsychobiology 37 (1998), 142–145.
40. Katsuura, S., Kuwano, Y., Yamagishi, N., Kurokawa, K., Kajita, K., Akaike, Y., et al. MicroRNAs miR-144/144* and miR-16 in peripheral blood are potential biomarkers for naturalistic stress in healthy Japanese medical students. Neurosci. Lett. 516 (2012), 79–84.
41. Kessler, R.C., Berglund, P., Demler, O., Jin, R., Merikangas, K.R., Walters, E.E., Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the national comorbidity survey Replication. Arch Gen Psychiatry 62 (2005), 593–602.
42. Kim, A.H., Reimers, M., Maher, B., Williamson, V., McMichael, O., McClay, J.L., et al. MicroRNA expression profiling in the prefrontal cortex of individuals affected with schizophrenia and bipolar disorders. Schizophr. Res. 124 (2010), 183–191.
43. Kim, D., Kim, J.W., Koo, T.H., Yun, H.R., Won, S.H., Shared and distinct neurocognitive endophenotypes of schizophrenia and psychotic bipolar disorder. Clin. Psychopharmacol. Neurosci. 13 (2015), 94–102.
44. Lachize, S., Apostolakis, E.M., van der Laan, S., Tijssen, A.M., Xu, J., de Kloet, E.R., et al. Steroid receptor coactivator-1 is necessary for regulation of corticotropin-releasing hormone by chronic stress and glucocorticoids. Proc. Natl. Acad. Sci. U. S. A. 106 (2009), 8038–8042.
45. Lewis, B.P., Burge, C.B., Bartel, D.P., Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120 (2005), 15–20.
46. Li, J.Z., Vawter, M.P., Walsh, D.M., Tomita, H., Evans, S.J., Choudary, P.V., et al. Systematic changes in gene expression in postmortem human brains associated with tissue pH and terminal medical conditions. Hum. Mol. Genet. 13 (2004), 609–616.
47. Livak, K.J., Schmittgen, T.D., Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25 (2001), 402–408.
48. Lohoff, F.W., Overview of the genetics of major depressive disorder. Curr. Psychiatry Rep. 12 (2010), 539–546.
49. Makeyev, E.V., Zhang, J., Carrasco, M.A., Maniatis, T., The MicroRNA miR-124 promotes neuronal differentiation by triggering brain-specific alternative pre-mRNA splicing. Mol. Cell. 27 (2007), 435–448.
50. Mayberg, H.S., Liotti, M., Brannan, S.K., McGinnis, S., Mahurin, R.K., Jerabek, P.A., et al. Reciprocal limbic-cortical function and negative mood: converging PET findings in depression and normal sadness. Am. J. Psychiatry 156 (1999), 675–682.
51. McGirr, A., Lipina, T.V., Mun, H.S., Georgiou, J., Al-Amri, A.H., Ng, E., et al. Specific inhibition of Phosphodiesterase-4B results in anxiolysis and facilitates memory acquisition. Neuropsychopharmacology 41:4 (2015), 1080–1092.
52. McGuffin, P., Rijsdijk, F., Andrew, M., Sham, P., Katz, R., Cardno, A., The heritability of bipolar affective disorder and the genetic relationship to unipolar depression. Arch. Gen. Psychiatry 60 (2003), 497–502.
53. Mellios, N., Huang, H.S., Grigorenko, A., Rogaev, E., Akbarian, S., A set of differentially expressed miRNAs, including miR-30a-5p, act as post-transcriptional inhibitors of BDNF in prefrontal cortex. Hum. Mol. Genet. 17 (2008), 3030–3042.
54. Millar, J.K., Pickard, B.S., Mackie, S., James, R., Christie, S., Buchanan, S.R., et al. DISC1 and PDE4B are interacting genetic factors in schizophrenia that regulate cAMP signaling. Science 310 (2005), 1187–1191.
55. Miller, B.H., Zeier, Z., Xi, L., Lanz, T.A., Deng, S., Strathmann, J., et al. MicroRNA-132 dysregulation in schizophrenia has implications for both neurodevelopment and adult brain function. Proc. Natl. Acad. Sci. U. S. A. 109 (2012), 3125–3130.
56. Moreau, M.P., Bruse, S.E., David-Rus, R., Buyske, S., Brzustowicz, L.M., Altered microRNA expression profiles in postmortem brain samples from individuals with schizophrenia and bipolar disorder. Biol. Psychiatry 69 (2011), 188–193.
57. Morgado, A.L., Xavier, J.M., Dionisio, P.A., Ribeiro, M.F., Dias, R.B., Sebastiao, A.M., et al. MicroRNA-34a modulates neural stem cell differentiation by regulating expression of synaptic and autophagic proteins. Mol. Neurobiol. 51:3 (2014), 1168–1183.
58. Muinos-Gimeno, M., Espinosa-Parrilla, Y., Guidi, M., Kagerbauer, B., Sipila, T., Maron, E., et al. Human microRNAs miR-22, miR-138-2, miR-148a, and miR-488 are associated with panic disorder and regulate several anxiety candidate genes and related pathways. Biol. Psychiatry 69 (2011), 526–533.
59. Mukherji, S., Ebert, M.S., Zheng, G.X., Tsang, J.S., Sharp, P.A., van Oudenaarden, A., MicroRNAs can generate thresholds in target gene expression. Nat. Genet. 43 (2011), 854–859.
60. Mulert, C., Juckel, G., Brunnmeier, M., Karch, S., Leicht, G., Mergl, R., et al. Rostral anterior cingulate cortex activity in the theta band predicts response to antidepressive medication. Clin. EEG Neurosci. 38 (2007), 78–81.
61. Nomura, T., Kimura, M., Horii, T., Morita, S., Soejima, H., Kudo, S., et al. MeCP2-dependent repression of an imprinted miR-184 released by depolarization. Hum. Mol. Genet. 17 (2008), 1192–1199.
62. Numata, S., Iga, J., Nakataki, M., Tayoshi, S., Taniguchi, K., Sumitani, S., et al. Gene expression and association analyses of the phosphodiesterase 4B (PDE4B) gene in major depressive disorder in the Japanese population. Am. J. Med. Genet. B Neuropsychiatr. Genet. 150B (2009), 527–534.
63. Padmos, R.C., Hillegers, M.H., Knijff, E.M., Vonk, R., Bouvy, A., Staal, F.J., et al. A discriminating messenger RNA signature for bipolar disorder formed by an aberrant expression of inflammatory genes in monocytes. Arch. Gen. Psychiatry 65 (2008), 395–407.
64. Perkins, D.O., Jeffries, C.D., Jarskog, L.F., Thomson, J.M., Woods, K., Newman, M.A., et al. microRNA expression in the prefrontal cortex of individuals with schizophrenia and schizoaffective disorder. Genome Biol., 8, 2007, R27.
65. Pickard, B.S., Thomson, P.A., Christoforou, A., Evans, K.L., Morris, S.W., Porteous, D.J., et al. The PDE4B gene confers sex-specific protection against schizophrenia. Psychiatr. Genet. 17 (2007), 129–133.
66. Pizzagalli, D., Pascual-Marqui, R.D., Nitschke, J.B., Oakes, T.R., Larson, C.L., Abercrombie, H.C., et al. Anterior cingulate activity as a predictor of degree of treatment response in major depression: evidence from brain electrical tomography analysis. Am. J. Psychiatry 158 (2001), 405–415.
67. Posner, M., DiGirolamo, G., Executive attention: conflict, target detection, and cognitive control. Parasuraman, R., (eds.) The Attentive Brain, 1998, MIT Press.
68. Purcell, S.M., Wray, N.R., Stone, J.L., Visscher, P.M., O'Donovan, M.C., Sullivan, P.F., et al. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 460 (2009), 748–752.
69. Qi, X.R., Kamphuis, W., Wang, S., Wang, Q., Lucassen, P.J., Zhou, J.N., et al. Aberrant stress hormone receptor balance in the human prefrontal cortex and hypothalamic paraventricular nucleus of depressed patients. Psychoneuroendocrinology 38 (2013), 863–870.
70. Rokavec, M., Li, H., Jiang, L., Hermeking, H., The p53/miR-34 axis in development and disease. J. Mol. Cell Biol. 6:3 (2014), 214–230.
71. Ruan, C.S., Zhou, F.H., He, Z.Y., Wang, S.F., Yang, C.R., Shen, Y.J., et al. Mice deficient for wild-type p53-induced phosphatase 1 display elevated anxiety- and depression-like behaviors. Neuroscience 293 (2015), 12–22.
72. Salvadore, G., Cornwell, B.R., Colon-Rosario, V., Coppola, R., Grillon, C., Zarate, C.A. Jr., et al. Increased anterior cingulate cortical activity in response to fearful faces: a neurophysiological biomarker that predicts rapid antidepressant response to ketamine. Biol. Psychiatry 65 (2009), 289–295.
73. Santarelli, D.M., Beveridge, N.J., Tooney, P.A., Cairns, M.J., Upregulation of dicer and microRNA expression in the dorsolateral prefrontal cortex Brodmann area 46 in schizophrenia. Biol. Psychiatry 69 (2011), 180–187.
74. Schratt, G.M., Tuebing, F., Nigh, E.A., Kane, C.G., Sabatini, M.E., Kiebler, M., et al. A brain-specific microRNA regulates dendritic spine development. Nature 439 (2006), 283–289.
75. Sempere, L.F., Freemantle, S., Pitha-Rowe, I., Moss, E., Dmitrovsky, E., Ambros, V., Expression profiling of mammalian microRNAs uncovers a subset of brain-expressed microRNAs with possible roles in murine and human neuronal differentiation. Genome Biol., 5, 2004, R13.
76. Shepherd, A.M., Quide, Y., Laurens, K.R., O'Reilly, N., Rowland, J.E., Mitchell, P.B., et al. Shared intermediate phenotypes for schizophrenia and bipolar disorder: neuroanatomical features of subtypes distinguished by executive dysfunction. J. Psychiatry Neurosci. 40 (2015), 58–68.
77. Shi, W., Du, J., Qi, Y., Liang, G., Wang, T., Li, S., et al. Aberrant expression of serum miRNAs in schizophrenia. J. Psychiatr. Res. 46 (2012), 198–204.
78. Sklar, P., Ripke, S., Scott, L.J., Adreassen, O.A., Cichon, S., Craddock, N., et al. Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4. Nat. Genet. 43:10 (2011), 977–983.
79. Smalheiser, N.R., Lugli, G., Zhang, H., Rizavi, H., Cook, E.H., Dwivedi, Y., Expression of microRNAs and other small RNAs in prefrontal cortex in schizophrenia, bipolar disorder and depressed subjects. PLoS One, 9, 2014, e86469.
80. Smoller, J.W., Finn, C.T., Family, twin, and adoption studies of bipolar disorder. Am. J. Med. Genet. C Semin. Med. Genet. 123C (2003), 48–58.
81. Sun, X.Y., Zhang, J., Niu, W., Guo, W., Song, H.T., Li, H.Y., et al. A preliminary analysis of microRNA as potential clinical biomarker for schizophrenia. Am. J. Med. Genet. B Neuropsychiatr. Genet. 168 (2015), 170–178.
82. Tan, L.P., Seinen, E., Duns, G., de Jong, D., Sibon, O.C., Poppema, S., et al. A high throughput experimental approach to identify miRNA targets in human cells. Nucleic Acids Res., 37, 2009, e137.
83. Tsai, S.J., Hong, C.J., Liou, Y.J., Chen, T.J., Chen, M.L., Hou, S.J., Yen, F.C., Yu, Y.W., Haplotype analysis of single nucleotide polymorphisms in the vascular endothelial growth factor (VEGFA) gene and antidepressant treatment response in major depressive disorder. Psychiatry Res. 169:2 (2009), 113–117.
84. van der Laan, S., Lachize, S.B., Vreugdenhil, E., de Kloet, E.R., Meijer, O.C., Nuclear receptor coregulators differentially modulate induction and glucocorticoid receptor-mediated repression of the corticotropin-releasing hormone gene. Endocrinology 149 (2008), 725–732.
85. Vreugdenhil, E., Verissimo, C.S., Mariman, R., Kamphorst, J.T., Barbosa, J.S., Zweers, T., et al. MicroRNA 18 and 124a down-regulate the glucocorticoid receptor: implications for glucocorticoid responsiveness in the brain. Endocrinology 150 (2009), 2220–2228.
86. Vythilingam, M., Vermetten, E., Anderson, G.M., Luckenbaugh, D., Anderson, E.R., Snow, J., et al. Hippocampal volume, memory, and cortisol status in major depressive disorder: effects of treatment. Biol. Psychiatry 56 (2004), 101–112.
87. Walker, R.M., Rybka, J., Anderson, S.M., Torrance, H.S., Boxall, R., Sussmann, J.E., et al. Preliminary investigation of miRNA expression in individuals at high familial risk of bipolar disorder. J. Psychiatr. Res. 62 (2015), 48–55.
88. Wan, Y., Liu, Y., Wang, X., Wu, J., Liu, K., Zhou, J., et al. Identification of differential microRNAs in cerebrospinal fluid and serum of patients with major depressive disorder. PLoS One, 10, 2015, e0121975.
89. Wilczynska, A., Bushell, M., The complexity of miRNA-mediated repression. Cell Death Differ. 22 (2015), 22–33.
90. Winnay, J.N., Xu, J., O'Malley, B.W., Hammer, G.D., Steroid receptor coactivator-1-deficient mice exhibit altered hypothalamic-pituitary-adrenal axis function. Endocrinology 147 (2006), 1322–1332.
91. Xie, X., Lu, J., Kulbokas, E.J., Golub, T.R., Mootha, V., Lindblad-Toh, K., et al. Systematic discovery of regulatory motifs in human promoters and 3′ UTRs by comparison of several mammals. Nature 434 (2005), 338–345.
92. Yu, J.Y., Chung, K.H., Deo, M., Thompson, R.C., Turner, D.L., MicroRNA miR-124 regulates neurite outgrowth during neuronal differentiation. Exp. Cell Res. 314 (2008), 2618–2633.
93. Yuan, P., Tragon, T., Xia, M., Leclair, C.A., Skoumbourdis, A.P., Zheng, W., et al. Phosphodiesterase 4 inhibitors enhance sexual pleasure-seeking activity in rodents. Pharmacol. Biochem. Behav. 98 (2011), 349–355.
94. Zeller, E., Stief, H.J., Pflug, B., Sastre-y-Hernandez, M., Results of a phase II study of the antidepressant effect of rolipram. Pharmacopsychiatry 17 (1984), 188–190.
95. Zhou, R., Yuan, P., Wang, Y., Hunsberger, J.G., Elkahloun, A., Wei, Y., Damschroder-Williams, P., Du, J., Chen, G., Manji, H.K., Evidence for selective microRNAs and their effectors as common long-term targets for the actions of mood stabilizers. Neuropsychopharmacology 34:6 (2009), 1395–1405.